Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Aurélien Lambert"'
Autor:
Julie Dardare, Andréa Witz, Margaux Betz, Aurélie François, Laureline Lamy, Marie Husson, Jessica Demange, Marie Rouyer, Aurélien Lambert, Jean-Louis Merlin, Pauline Gilson, Alexandre Harlé
Publikováno v:
Cell Death Discovery, Vol 10, Iss 1, Pp 1-10 (2024)
Abstract Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers. Therapeutic options for PDAC are primarily restricted to surgery in the early stages of the disease or chemotherapy in advanced disease. Only a subset of patients with
Externí odkaz:
https://doaj.org/article/f812e69c8e8e400f9dc2fa11b2a0a91f
Publikováno v:
International Journal of Qualitative Methods, Vol 23 (2024)
This article examines the influence that digital life stories (DLS) can have on cancer research, using the PARCA1 project as an example. After describing the theoretical framework of DLS, we present the PARCA1 project. The PARCA1 project was anchored
Externí odkaz:
https://doaj.org/article/a1de0ab12553452288a9b4239a86c144
Autor:
Julie Dardare, Andréa Witz, Margaux Betz, Aurélie Francois, Morgane Meras, Laureline Lamy, Aurélien Lambert, Stéphanie Grandemange, Marie Husson, Marie Rouyer, Jessica Demange, Jean-Louis Merlin, Alexandre Harlé, Pauline Gilson
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
IntroductionDamage specific DNA binding protein 2 (DDB2) is an UV-indiced DNA damage recognition factor and regulator of cancer development and progression. DDB2 has dual roles in several cancers, either as an oncogene or as a tumor suppressor gene,
Externí odkaz:
https://doaj.org/article/a3ca4813d8d344d2a4dc2b42439f7ed6
Autor:
Ke Zhou, Jean-Luc Raoul, Audrey Blanc-Lapierre, Valérie Seegers, Michèle Boisdron-Celle, Marianne Bourdon, Hakim Mahammedi, Aurélien Lambert, Camille Moreau-Bachelard, Mario Campone, Thierry Conroy, Frédérique Penault-Llorca, Martine M Bellanger, Frédéric Bigot
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 16 (2022)
Background: Cancer patients (CPs) are considered more vulnerable and as a high mortality group regarding COVID-19. In this analysis, we aimed to describe asymptomatic COVID (+) CPs and associated factors. Methods: We conducted a prospective study in
Externí odkaz:
https://doaj.org/article/c904ab906e364ff9a913c197daea705d
Autor:
Claire Franczak, Andréa Witz, Karen Geoffroy, Jessica Demange, Marie Rouyer, Marie Husson, Vincent Massard, Céline Gavoille, Aurélien Lambert, Pauline Gilson, Nicolas Gambier, Julien Scala-Bertola, Jean-Louis Merlin, Alexandre Harlé
Publikováno v:
PLoS ONE, Vol 15, Iss 1, p e0227294 (2020)
BACKGROUND:Cell-free DNA detection is becoming a surrogate assay for tumor genotyping. Biological fluids often content a very low amount of cell-free tumor DNA and assays able to detect very low allele frequency mutant with a few quantities of DNA ar
Externí odkaz:
https://doaj.org/article/2d2a0901bd524592b14f78b4b389cbf9
Autor:
Aurélien Lambert, Lilian Schwarz, Ivan Borbath, Aline Henry, Jean-Luc Van Laethem, David Malka, Michel Ducreux, Thierry Conroy
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 11 (2019)
Pancreatic cancer is one of the most lethal solid organ tumors. Due to the rising incidence, late diagnosis, and limited treatment options, it is expected to be the second leading cause of cancer deaths in high income countries in the next decade. Th
Externí odkaz:
https://doaj.org/article/41f96730b9944ccb8bad45d3dd44a0ac
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 10 (2017)
Pancreatic cancer (PC) incidence rates are rapidly increasing in developed countries, with half the patients being metastatic at diagnosis. For decades, fluorouracil, then gemcitabine regimens were the preferred palliative first-line options for fit
Externí odkaz:
https://doaj.org/article/27a1f3e16cd4408cbb928db5f126f66f
Publikováno v:
PLoS ONE, Vol 12, Iss 9, p e0183288 (2017)
Hohla et al. suggested that female gender could positively predict response to FOLFIRINOX in patients with advanced pancreatic cancer. In this study, we explored the response to the FOLFIRINOX regimen by gender within the trial PRODIGE4/ACCORD 11.Dat
Externí odkaz:
https://doaj.org/article/8906c293b1784ab59afcc545943783b3
Autor:
Thierry, Conroy, Florence, Castan, Anthony, Lopez, Anthony, Turpin, Meher, Ben Abdelghani, Alice C, Wei, Emmanuel, Mitry, James J, Biagi, Ludovic, Evesque, Pascal, Artru, Thierry, Lecomte, Eric, Assenat, Lucile, Bauguion, Marc, Ychou, Olivier, Bouché, Laure, Monard, Aurélien, Lambert, Pascal, Hammel, Chris, O'Callaghan
Publikováno v:
JAMA oncology. 8(11)
ImportanceEarly results at 3 years from the PRODIGE 24/Canadian Cancer Trials Group PA6 randomized clinical trial showed survival benefits with adjuvant treatment with modified FOLFIRINOX vs gemcitabine in patients with resected pancreatic ductal ade
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d98f64a986454986ad7045715dc306c2
https://pubmed.ncbi.nlm.nih.gov/36416803
https://pubmed.ncbi.nlm.nih.gov/36416803
Autor:
Cécile Torregrosa, Simon Pernot, Pauline Vaflard, Audrey Perret, Christophe Tournigand, Violaine Randrian, Solene Doat, Cindy Neuzillet, Valérie Moulin, Morgane Stouvenot, Gael Roth, Tiffany Darbas, Benjamin Auberger, Tiphaine Godet, Marion Jaffrelot, Aurélien Lambert, Olivier Dubreuil, Cassandre Gluszak, Alice Bernard‐Tessier, Anthony Turpin, Lola‐Jade Palmieri, Olivier Bouche, Gael Goujon, Thierry Lecomte, David Sefrioui, Christophe Locher, Lucien Grados, Pauline Gignoux, Stéphanie Trager, Elise Nassif, Angélique Saint, Pascal Hammel, Cédric Lecaille, Mathilde Bureau, Marine Perrier, Damien Botsen, Vincent Bourgeois, Julien Taieb, Edouard Auclin
Publikováno v:
International Journal of Cancer. 151:1978-1988
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::09d72c9a0704a82a69ad9ebee3972fc1
https://doi.org/10.1002/ijc.34166
https://doi.org/10.1002/ijc.34166